HomePHAT • NASDAQ
add
Phathom Pharmaceuticals Inc
Previous close
$13.49
Day range
$13.07 - $13.99
Year range
$2.21 - $19.05
Market cap
944.72M USD
Avg Volume
1.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 49.50M | 202.74% |
Operating expense | 58.58M | -30.91% |
Net income | -29.97M | 64.98% |
Net profit margin | -60.55 | 88.43% |
Earnings per share | -0.15 | 85.71% |
EBITDA | -15.12M | 78.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 135.16M | -59.62% |
Total assets | 240.29M | -37.92% |
Total liabilities | 662.82M | 15.44% |
Total equity | -422.53M | — |
Shares outstanding | 71.14M | — |
Price to book | -2.27 | — |
Return on assets | -15.57% | — |
Return on capital | -23.19% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -29.97M | 64.98% |
Cash from operations | -14.12M | 77.80% |
Cash from investing | -27.00K | 38.64% |
Cash from financing | -271.00K | -100.22% |
Net change in cash | -14.41M | -124.66% |
Free cash flow | -14.60M | 71.91% |
About
Founded
2018
Headquarters
Website
Employees
427
